Veugelers M, De Cat B, Ceulemans H et al (1999) Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans. J Biol Chem 274:26968–26977. https://doi.org/10.1074/jbc.274.38.26968

Article  CAS  PubMed  Google Scholar 

Filmus J, Capurro M, Rast J (2009) Glypicans. Genome Biol 9:224. https://doi.org/10.1186/gb-2008-9-5-224

Tarbell JM, Cancel LM (2016) The glycocalyx and its significance in human medicine. J Intern Med 280:97–113. https://doi.org/10.1111/JOIM.12465

Article  CAS  PubMed  Google Scholar 

Reitsma S, Slaaf DW, Vink H et al (2007) The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 454:345–359. https://doi.org/10.1007/S00424-007-0212-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thota LNR, Chignalia AZ (2022) The role of the glypican and syndecan families of heparan sulfate proteoglycans in cardiovascular function and disease. Am J Physiol Cell Physiol 323:C1052–C1060. https://doi.org/10.1152/AJPCELL.00018.2022

Article  CAS  PubMed  Google Scholar 

Fico A, Maina F, Dono R (2011) Fine-tuning of cell signaling by glypicans. Cell Mol Life Sci 68:923–929. https://doi.org/10.1007/S00018-007-7471-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watanabe K, Yamada H, Yamaguchi Y (1995) K-glypican: A novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney. J Cell Biol 130:1207–1218. https://doi.org/10.1083/jcb.130.5.1207

Article  CAS  PubMed  Google Scholar 

Allen NJ, Bennett ML, Foo LC et al (2012) Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 486:410–414. https://doi.org/10.1038/NATURE11059

Article  CAS  PubMed  PubMed Central  Google Scholar 

Farhy-Tselnicker I, van Casteren ACM, Lee A et al (2017) Astrocyte-Secreted Glypican 4 Regulates Release of Neuronal Pentraxin 1 from Axons to Induce Functional Synapse Formation. Neuron 96:428-445.e13. https://doi.org/10.1016/J.NEURON.2017.09.053

Article  CAS  PubMed  PubMed Central  Google Scholar 

Strate I, Tessadori F, Bakkers J (2015) Glypican4 promotes cardiac specification and differentiation by attenuating canonical Wnt and Bmp signaling. Dev 142:1767–1776. https://doi.org/10.1242/dev.113894

Article  CAS  Google Scholar 

Corti S, Bonjean R, Legier T et al (2021) Enhanced differentiation of human induced pluripotent stem cells toward the midbrain dopaminergic neuron lineage through GLYPICAN-4 downregulation. Stem Cells Transl Med 10:725–742. https://doi.org/10.1002/SCTM.20-0177

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fico A, De Chevigny A, Egea J et al (2012) Modulating Glypican4 suppresses tumorigenicity of embryonic stem cells while preserving self-renewal and pluripotency. Stem Cells 30:1863–1874. https://doi.org/10.1002/STEM.1165

Article  CAS  PubMed  Google Scholar 

Karihaloo A, Kale S, Rosenblum ND, Cantley LG (2004) Hepatocyte growth factor-mediated renal epithelial branching morphogenesis is regulated by glypican-4 expression. Mol Cell Biol 24:8745–8752. https://doi.org/10.1128/MCB.24.19.8745-8752.2004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gesta S, Blühet M, Yamamoto Y et al (2006) Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A 103:6676–6681. https://doi.org/10.1073/pnas.0601752103

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ussar S, Bezy O, Blüher M, Kahn CR (2012) Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine. Diabetes 61:2289–2298. https://doi.org/10.2337/DB11-1395

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li K, Xu X, Hu W et al (2014) Glypican-4 is increased in human subjects with impaired glucose tolerance and decreased in patients with newly diagnosed type 2 diabetes. Acta Diabetol 51:981–990. https://doi.org/10.1007/S00592-014-0652-5

Article  CAS  PubMed  Google Scholar 

Huber R, Mazzarella R, Chen CN et al (1998) Glypican 3 and glypican 4 are juxtaposed in Xq26.1. Gene 225:9–16. https://doi.org/10.1016/S0378-1119(98)00549-6

Article  CAS  PubMed  Google Scholar 

Urschel K, Hug KP, Zuo H et al (2023) The shear stressregulated expression of glypican-4 in endothelial dysfunction in vitro and its clinical significance in atherosclerosis. Int J Mol Sci 24:11595. https://doi.org/10.3390/ijms241411595

Metz CN, Brunner G, Choi-Muira NH et al (1994) Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. EMBO J 13:1741–1751. https://doi.org/10.1002/J.1460-2075.1994.TB06438.X

Article  CAS  PubMed  PubMed Central  Google Scholar 

Traister A, Shi W, Filmus J (2008) Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface. Biochem J 410:503–511. https://doi.org/10.1042/BJ20070511

Article  CAS  PubMed  Google Scholar 

Kakugawa S, Langton PF, Zebisch M et al (2015) Notum deacylates Wnt proteins to suppress signalling activity. Nature 519:187–192. https://doi.org/10.1038/NATURE14259

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang K, Park S (2021) Heparan sulfated glypican-4 is released from astrocytes by proteolytic shedding and GPI-anchor cleavage mechanisms. Eneuro 8(4). https://doi.org/10.1523/ENEURO.0069-21.2021

Saroja SR, Gorbachev K, Tcw J et al (2022) Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation. Proc Natl Acad Sci U S A 119:e2108870119. https://doi.org/10.1073/PNAS.2108870119

Lepedda AJ, Nieddu G, Piperigkou Z et al (2021) Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease. Semin Thromb Hemost 47:295–307. https://doi.org/10.1055/s-0041-1725063

Article  CAS  PubMed  Google Scholar 

Fisher J, Linder A, Bentzer P (2019) Elevated plasma glypicans are associated with organ failure in patients with infection. Intensive Care Med Exp 7:2. https://doi.org/10.1186/S40635-018-0216-Z

Ebong EE, Lopez-Quintero SV, Rizzo V et al (2014) Shear-induced endothelial NOS activation and remodeling via heparan sulfate, glypican-1, and syndecan-1. Integr Biol (Camb) 6:338–347. https://doi.org/10.1039/C3IB40199E

Article  CAS  PubMed  Google Scholar 

Suzuki K, Miura T, Okada H (2023) The endothelial glycocalyx-all the same? No, it is not. Acute Med Surg 10:e896. https://doi.org/10.1002/AMS2.896

Teo A, Chan LLY, Cheung C et al (2023) Myeloperoxidase inhibition may protect against endothelial glycocalyx shedding induced by COVID-19 plasma. Commun Med 3:62. https://doi.org/10.1038/S43856-023-00293-X

Li J, Wang T, Jin B et al (2018) Diagnosis accuracy of serum glypican-3 level in patients with hepatocellular carcinoma: a systematic review with meta-analysis. Int J Biol Markers 33:353–363. https://doi.org/10.1177/1724600818784409

Article  CAS  PubMed  Google Scholar 

Guo M, Zhang H, Zheng J, Liu Y (2020) Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma. J Cancer 11:2008–2021. https://doi.org/10.7150/JCA.39972

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu D, Su C, Sun L et al (2019) Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis. Ann Hepatol 18:58–67. https://doi.org/10.5604/01.3001.0012.7863

Article  CAS  PubMed  Google Scholar 

Ning DP, Xu K, Zhu HJ et al (2019) Serum Glypican 4 Levels Are Associated with Metabolic Syndrome in a Han Population from Guizhou Province, China. Biomed Environ Sci 32:383–388. https://doi.org/10.3967/bes2019.052

Article  CAS  PubMed  Google Scholar